Physician profile
Laurae Mitchell
NPI 1063759223
$5,945.65
in general payments reported to CMS, 2019-2025
17 companies · $2,922 in 2025
The $2,922 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $337 · 2023: $944 · 2024: $1,575 · 2025: $2,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,817 · Consulting Fee: $1,140 · Education: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,816.50 |
| Consulting Fee | $1,140.00 |
| Education | $484.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,389.46 | 2023-2025 | Bimzelx |
| Janssen Biotech, INC. | $1,238.67 | 2021-2025 | Tremfya |
| Abbvie INC. | $1,009.26 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $452.89 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $382.19 | 2023-2025 | |
| Amgen INC. | $267.74 | 2023-2025 | Otezla, Otezla |
| Lilly USA, LLC | $228.29 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $217.43 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $208.09 | 2021-2024 | Ilumya, Winlevi, Absorica Ld |
| Leo Pharma INC. | $203.24 | 2023-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $139.19 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $73.59 | 2023-2025 | Dupixent, Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.93 | 2022-2025 | Spevigo |
| Incyte Corporation | $38.93 | 2023 | Opzelura |
| Almirall LLC | $24.01 | 2024 | Seysara |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $15.54 | 2024 | Vtama |
| Organon LLC | $7.20 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurae Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.